ORAMED PHARMACEUTICALS INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2025
Total Assets: $230.9M
Liabilities Breakdown FY2025
Total Liabilities: $31.1M
Asset Breakdown
Total Assets: $230.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.9M | 19.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $586.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $184.3M | 79.8% |
Liabilities Breakdown
Total Liabilities: $31.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $443.0K | 1.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $30.7M | 98.6% |